BrainLAB wins patent lawsuit The U.S. Courtroom of Appeals for the Federal government Circuit provides upheld the dismissal of the patent infringement lawsuit filed by Medtronic against BrainLAB AG in 1998. The appellate court affirmed a prior district courtroom ruling that BrainLAB image-guided medical procedures and radiotherapy products usually do not infringe the patents in match. In February 2006, the united states District Courtroom in Denver, Colorado, dismissed Medtronic’s patent infringement lawsuit, discovering that BrainLAB products usually do not infringe some of Medtronic’s patents in fit.But where in fact the legislation would deter retailers from offering a wide variety of legitimate products to consumers or would overburden producers, we will seek alternate solutions. Dietary supplements employ a strong safety profile and customers should continue to feel confident in the supplements that they are acquiring. Our individuals are our industry’s greatest asset and CRN is still dedicated to ensuring that consumers get access to safe, beneficial products that may positively impact their health. .. Bayer announces Wellness Canada authorization of Nexavar for differentiated thyroid tumor treatment Bayer Inc. Is very happy to announce medical Canada authorization of Nexavar for the treating individuals with locally advanced or metastatic, progressive, differentiated thyroid carcinoma , refractory to radioactive iodine .